Multicenter study of 9-AC [IDEC 132] in refractory leukemia.

Trial Profile

Multicenter study of 9-AC [IDEC 132] in refractory leukemia.

Phase of Trial: Phase I

Latest Information Update: 09 Mar 2011

At a glance

  • Drugs IDEC 132 (Primary)
  • Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Dec 2007 Status changed from in progress to completed.
    • 29 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top